Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function
Conditions: Alcoholic Hepatitis Interventions: Biological: Plasma Exchange; Other: Standard Medical Treatment Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Oral Tablet Sponsors: Ann& Robert H Lurie Children ' s Hospital of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Conditions: Insulin Resistance; Prediabetic State; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Alpelisib 300 mg; Drug: Placebo; Drug: [1-13C] sodium acetate; Drug: [6,6-2H2] D-glucose; Dietary Supplement: Nestl é BOOST Plus Sponsors: Columbia University; University of California, Berkeley Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Motivational Interview; Behavioral: Placebo Sponsors: Madunil Anuk Niriella Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1; NASH Interventions: Drug: Dipeptidyl peptidase 4 (DPP-4) inhibitor Sponsors: Ain Shams University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
Conditions: Alcohol Use Disorder Interventions: Drug: Psilocybin; Other: Inactive Placebo; Behavioral: Supportive therapy sessions Sponsors: NYU Langone Health; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Conditions: Addiction; Alcohol; Nicotine; Drugs; Personality; Depression; Anxiety Sponsors: Central Institute of Mental Health, Mannheim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease NAFLD Interventions: Behavioral: Aerobic training (AT); Behavioral: Resistance training (RT); Behavioral: Combined aerobic and resistance training (AT + RT) Sponsors: Xuzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
Conditions: All Cause Mortality; Cardiovascular Diseases; Invasive Cancer; Liver Cirrhosis; Type 2 Diabetes; Depression; Dementia; Injury Traumatic; Tuberculosis; Infections Interventions: Behavioral: Moderate Alcohol Drinking Pattern; Behavioral: Abstention Sponsors: Clinica Universidad de Navarra, Universidad de Navarra Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Manual Therapy in Metabolic Liver Disease
Conditions: NAFLD, Non-alcoholic Fatty Liver Disease Interventions: Procedure: liver treatment protocol Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
Conditions: Alcohol Use Disorder; Alcohol; Harmful Use Interventions: Behavioral: SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) Sponsors: University of California, Riverside Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Conditions: Alcohol Use Disorder (AUD); Post Traumatic Stress Disorder (PTSD) Interventions: Drug: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40 µg; Drug: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg Sponsors: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance; United States Department of Defense; Congressionally Directed Medical Research Programs; VA Connecticut Healthcare System; BioXcel Therapeutics Inc; Yale University; RTI International Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students
Conditions: Alcohol Use Disorder Interventions: Behavioral: PST-APPLE Watch group; Behavioral: Education-only control group Sponsors: University of Illinois at Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality
Conditions: Alcohol Dependence Interventions: Device: VR Cue-Exposure Therapy Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Individual Placement and Support for persons with alcohol and drug addiction in a Swedish context (IPS-ADAS): study protocol for a randomised controlled trial
DiscussionA primary study on the effectiveness of IPS on employment for the new target group of addictions will add to the international IPS knowledge base and inform national policy to include the underrepresented group in working life.Trial registrationWHO International Clinical Trials Registry Platform ISRCTN10492363. Registered on 14 August 2023. (Source: Trials)
Source: Trials - March 27, 2024 Category: Research Source Type: clinical trials
